Achmea Investment Management B.V. Novavax Inc Transaction History

Achmea Investment Management B.V.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$36.28 - $75.29 $32,144 - $66,706	-886 Reduced 14.02%	5,433 $279,000
Q1 2022 May 16, 2022	BUY	$69.73 - $142.9 $440,623 - $902,985	6,319 New	6,319 $465,000
Q4 2021 Feb 10, 2022	SELL	$134.56 - $217.97 $956,856 - $1.55 Million	-7,111 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$177.8 - $270.58 $25,603 - $38,963	144 Added 2.07%	7,111 $1.47 Million
Q2 2021 Aug 06, 2021	BUY	$121.0 - $257.67 $843,007 - $1.8 Million	6,967 New	6,967 $1.48 Million

290

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Achmea Investment Management B.V., based on Form 13F filings with the SEC.

Stay updated on Achmea Investment Management B.V. with notifications on news.